08 Nov 2006 -
KINAXO Biotechnologies GmbH announced that it has entered into a services and collaboration agreement with UCB S.A. of Brussels, Belgium (UCB). Under the agreement, KINAXO will employ the KinaTorTM technology to perform selectivity analyses for several of UCB's small molecule lead compounds in cells and tissue samples.